Prognostic Factors of Patients With ADHF

Chongqing Medical University362 enrolled

Overview

To explore the prognostic indicators for patients with ADHF

According to ESC Guidelines for the diagnosis of acute heart failure 2008, patients with ADHF were diagnosed, and their medical history, laboratory examination and treatment plan were retrospectively analyzed, and the patients were followed up for 1 year. The 1-year outcomes of patients were analyzed to explore the prognostic indicators for patients with ADHF

Study Type

OBSERVATIONAL

Enrollment

362

Conditions

Acute Decompensated Heart Failure

Interventions

elevated monocyte countOTHER

The monocyte count at admission was higher than 0.445×10\*9 cells/L

Eligibility

Sex: ALLMin age: 18 YearsMax age: 94 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with ADHF diagnosed according to ESC Guidelines for the diagnosis of acute heart failure 2008 Exclusion Criteria: * disorders of the hematopoietic system, history of cancer and/or previous treatment with chemotherapy, the infection caused by various pathogens, chronic inflammatory conditions, glucocorticoid therapy and/or histories of glucocorticoid use 3 months before the admission and acute myocardial infarction or coronary revascularization within the past 6 months. Also, patients who did not have a differential WBC count or who were lost to follow-up were excluded.

Outcomes

Primary Outcomes

all-cause death

The primary end point was one-year all-cause death

Time frame: 1 year

Secondary Outcomes

HF-related rehospitalization

the secondary end point was one-year HF-related rehospitalization.

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.